Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Application of current knowledge to the management of bleeding events during immune tolerance induction.

Di Paola J, Aledort L, Britton H, Carcao M, Grabowski E, Hutter J, Journeycake J, Kempton C, Leissinger C.

Haemophilia. 2006 Nov;12(6):591-7. Review.

PMID:
17083508
2.

Optimizing management of immune tolerance induction in patients with severe haemophilia A and inhibitors: towards evidence-based approaches.

Coppola A, Di Minno MN, Santagostino E.

Br J Haematol. 2010 Sep;150(5):515-28. doi: 10.1111/j.1365-2141.2010.08263.x. Epub 2010 Jun 22. Review.

PMID:
20573153
3.

Immune tolerance induction: a role for recombinant activated factor VII (rFVIIa)?

Brackmann HH, Effenberger W, Hess L, Schwaab R, Oldenburg J.

Eur J Haematol Suppl. 1998;63:18-23. Review.

PMID:
9882928
4.

The management of inhibitors in haemophilia A: introduction and systematic review of current practice.

Paisley S, Wight J, Currie E, Knight C.

Haemophilia. 2003 Jul;9(4):405-17. Review.

PMID:
12828677
5.

Immune tolerance induction in patients with haemophilia A with inhibitors: a systematic review.

Wight J, Paisley S, Knight C.

Haemophilia. 2003 Jul;9(4):436-63. Review.

PMID:
12828679
6.

Hemophilia. Strategies for the treatment of inhibitor patients.

Ingerslev J.

Haematologica. 2000 Oct;85(10 Suppl):15-20. Review.

PMID:
11187863
7.

The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation.

Hay CR, Brown S, Collins PW, Keeling DM, Liesner R.

Br J Haematol. 2006 Jun;133(6):591-605. Review.

PMID:
16704433
8.

Control of bleeding in patients with haemophilia A with inhibitors: a systematic review.

Lloyd Jones M, Wight J, Paisley S, Knight C.

Haemophilia. 2003 Jul;9(4):464-520. Review.

PMID:
12828680
9.

Inhibitors of factor VIII: detection and treatment.

Brettler DB.

Southeast Asian J Trop Med Public Health. 1993;24 Suppl 1:21-5. Review.

PMID:
7886576
10.

How we treat a hemophilia A patient with a factor VIII inhibitor.

Kempton CL, White GC 2nd.

Blood. 2009 Jan 1;113(1):11-7. doi: 10.1182/blood-2008-06-160432. Epub 2008 Sep 26. Review.

11.

Immune tolerance induction for the eradication of inhibitors in patients with hemophilia A.

Kruse-Jarres R, Barnett B, Leissinger C.

Expert Opin Biol Ther. 2008 Dec;8(12):1885-96. doi: 10.1517/14712590802515537 . Review.

PMID:
18990076
12.

Epidemiology of inhibitors and current treatment strategies.

Kreuz W, Ettingshausen CE, Auerswald G, Saguer IM, Becker S, Funk M, Heller C, Klarmann D, Klingebiel T; GTH PUP Study Group.

Haematologica. 2003 Jun;88(6):EREP04. Review.

PMID:
12826530
13.

Prophylaxis in haemophilia patients with inhibitors.

Leissinger CA.

Haemophilia. 2006 Dec;12 Suppl 6:67-72; discussion 72-3. Review.

PMID:
17123397
14.

Treatment options for bleeding episodes in patients undergoing immune tolerance therapy.

Manno CS.

Haemophilia. 1999 Sep;5 Suppl 3:33-41. Review.

PMID:
10597386
15.
16.

Management of patients with factor VIII inhibitors.

Lusher JM.

Transfus Med Rev. 1987 Aug;1(2):123-30. Review.

PMID:
2980269
17.

Hemophilia factor VIII therapy. Immunological tolerance. A clinical perspective.

White GC 2nd, Greenwood R, Escobar M, Frelinger JA.

Haematologica. 2000 Oct;85(10 Suppl):113-6. Review.

PMID:
11187862
18.

The role of VWF for the success of immune tolerance induction.

Kreuz W.

Thromb Res. 2008;122 Suppl 2:S7-S12. doi: 10.1016/S0049-3848(08)70003-3. Review.

PMID:
18549910
19.

Immune tolerance: critical issues of factor dose, purity and treatment complications.

DiMichele DM.

Haemophilia. 2006 Dec;12 Suppl 6:81-5; discussion 85-6. Review.

PMID:
17123399
20.

Economic modelling of different treatment strategies for haemophilia A with high-responding inhibitors.

Knight C, Paisley S, Wight J, Jones ML.

Haemophilia. 2003 Jul;9(4):521-40. Review.

PMID:
12828681

Supplemental Content

Support Center